Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXELIXIS, INC. Director's Dealing 2020

May 9, 2020

30561_dirs_2020-05-08_beace03e-900a-4ee4-9fc8-940ddddaf394.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXELIXIS, INC. (EXEL)
CIK: 0000939767
Period of Report: 2020-05-08

Reporting Person: Haley Patrick J. (EVP, Commercial)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-08 Common Stock M 21375 $1.76 Acquired 139866 Direct
2020-05-08 Common Stock S 21375 $25.87 Disposed 118491 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-08 Option (right to buy) $1.76 M 21375 Disposed 2021-11-16 Common Stock (21375.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 23539 Indirect
Common Stock 10648 Indirect

Footnotes

F1: Includes 72,614 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 1,618 shares of common stock acquired on April 30, 2020, pursuant to the Exelixis, Inc. 2000 Employee Stock Purchase Plan.

F2: Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $25.79 to $25.88. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.

F3: Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of May 7, 2020.

F4: The option, representing the right to purchase a total of 50,000 shares of Exelixis, Inc. common stock, became fully exercisable on November 17, 2018